Abemaciclib-associated acute interstitial nephritis successfully treated with glucocorticoids: a case report and literature review
Open Access
- 29 September 2025
- journal article
- case report
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-7
Abstract
Background: Drug-induced acute interstitial nephritis (DI-AIN) is the most common type of AIN. DI-AIN occurs when medications trigger a T cell-mediated immune response that promotes tubulitis and interstitial inflammation with eosinophils, often resulting in acute kidney injury (AKI) with nephromegaly. Recently, prolonged use of cyclin-dependent kinase (CDK) 4/6 inhibitors, as oral molecular-targeted drugs for breast cancer, was identified as a cause of AKI, including AIN and acute tubular necrosis (ATN). To date, there have been no reported cases of AIN associated with the use of abemaciclib, a CDK4/6 inhibitor. Case presentation: A 66-year-old Japanese woman presented with persistent diarrhea and nausea shortly after the initiation of abemaciclib for breast cancer and was subsequently referred to our hospital with severe renal dysfunction (blood urea nitrogen, 128.7 mg/dL; creatinine, 15.16 mg/dL). Based on her elevated renal tubular damage markers and bilateral renal enlargement, acute renal failure was suspected. A renal biopsy revealed interstitial infiltration of mononuclear cells and eosinophils, along with tubulitis and epithelial cell damage within the renal tubules, suggesting AIN caused by abemaciclib. The renal function improved with glucocorticoid therapy following fluid replacement for pre-renal AKI, and the serum creatinine decreased to approximately 2 mg/dL within 2 months. Conclusions: We report a case of biopsy-proven AIN that developed shortly after the initiation of abemaciclib, leading to severe renal dysfunction with nephromegaly. While prolonged use of CDK4/6 inhibitors can cause both AIN and ATN, AIN can also occur after short-term use, highlighting the importance of a renal biopsy to determine the need for glucocorticoid therapy. Clinical trial number: Not applicable.Keywords
This publication has 22 references indexed in Scilit:
- Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearanceClinical and Experimental Nephrology, 2011
- Drug-induced acute interstitial nephritisNature Reviews Nephrology, 2010
- Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritisKidney International, 2008
- Acute interstitial nephritis: clinical features and response to corticosteroid therapyNephrology Dialysis Transplantation, 2004
- The changing profile of acute tubulointerstitial nephritisNephrology Dialysis Transplantation, 2004
- The Leptospira Outer Membrane Protein LipL32 Induces Tubulointerstitial Nephritis-Mediated Gene Expression in Mouse Proximal Tubule CellsJournal of the American Society of Nephrology, 2002
- Drug-induced acute interstitial nephritisKidney International, 2001
- Acute interstitial nephritis in the elderly: a report from the UK MRC glomerulonephritis register and a review of the literatureNephrology Dialysis Transplantation, 1998
- Acute Interstitial Nephritis: A Clinical and Morphological Study in 27 PatientsNephrology Dialysis Transplantation, 1990
- RENAL BIOPSY IN PATIENTS WITH UNEXPLAINED RENAL IMPAIRMENT AND NORMAL KIDNEY SIZE1989